| Secondary |
| Product Used For Unknown Indication |
38.0% |
| Drug Use For Unknown Indication |
12.0% |
| Crohn's Disease |
11.7% |
| Depression |
8.4% |
| Pain |
6.4% |
| Ill-defined Disorder |
5.2% |
| Mental Disorder |
2.7% |
| Bipolar Disorder |
2.2% |
| Anxiety |
1.4% |
| Completed Suicide |
1.4% |
| Back Pain |
1.2% |
| Hypertension |
1.2% |
| Schizoaffective Disorder |
1.2% |
| Insomnia |
1.1% |
| Suicide Attempt |
1.1% |
| Blood Cholesterol Increased |
1.0% |
| Cardiac Failure Chronic |
1.0% |
| Drug Abuse |
1.0% |
| Hormone Level Abnormal |
1.0% |
| Neuralgia |
1.0% |
|
| Suicide Attempt |
9.5% |
| Weight Decreased |
9.5% |
| Overdose |
7.9% |
| Completed Suicide |
7.1% |
| Withdrawal Syndrome |
7.1% |
| Toxicity To Various Agents |
6.3% |
| Tremor |
6.3% |
| Death |
5.6% |
| Drug Interaction |
4.8% |
| Substance Abuse |
4.8% |
| Weight Increased |
4.8% |
| Respiratory Arrest |
4.0% |
| Suicidal Ideation |
4.0% |
| Serotonin Syndrome |
3.2% |
| Vomiting |
3.2% |
| Accidental Overdose |
2.4% |
| Drug Toxicity |
2.4% |
| Intentional Overdose |
2.4% |
| Multiple Drug Overdose Intentional |
2.4% |
| Poisoning |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.9% |
| Depression |
15.7% |
| Drug Use For Unknown Indication |
12.5% |
| Crohn's Disease |
9.5% |
| Hypertension |
9.3% |
| Smoking Cessation Therapy |
4.7% |
| Pain |
4.4% |
| Diabetes Mellitus |
3.7% |
| Multiple Sclerosis |
3.3% |
| Osteoporosis |
2.8% |
| Insomnia |
2.0% |
| Anxiety |
1.9% |
| Bipolar Disorder |
1.8% |
| Back Pain |
1.7% |
| Sleep Disorder |
1.6% |
| Breast Cancer |
1.5% |
| Fibromyalgia |
1.3% |
| Premedication |
1.2% |
| Psoriasis |
1.2% |
| Hepatitis C |
1.1% |
|
| Vomiting |
13.6% |
| Depression |
8.9% |
| Suicidal Ideation |
8.9% |
| Suicide Attempt |
7.9% |
| Weight Decreased |
7.5% |
| Nausea |
7.3% |
| Weight Increased |
6.8% |
| Somnolence |
5.3% |
| Drug Ineffective |
4.0% |
| Death |
3.8% |
| Insomnia |
3.6% |
| Tremor |
3.0% |
| Fatigue |
2.8% |
| Urticaria |
2.8% |
| Pain In Extremity |
2.4% |
| Pneumonia |
2.4% |
| Oedema Peripheral |
2.3% |
| Syncope |
2.3% |
| Vision Blurred |
2.3% |
| Wrong Technique In Drug Usage Process |
2.3% |
|
| Interacting |
| Depression |
29.7% |
| Ill-defined Disorder |
18.9% |
| Anxiety |
10.8% |
| Pain |
10.8% |
| Drug Use For Unknown Indication |
8.1% |
| Product Used For Unknown Indication |
5.4% |
| Smoking Cessation Therapy |
5.4% |
| Attention Deficit/hyperactivity Disorder |
2.7% |
| Multiple Sclerosis |
2.7% |
| Oropharyngeal Pain |
2.7% |
| Post-traumatic Stress Disorder |
2.7% |
|
| Drug Interaction |
29.4% |
| Anxiety |
11.8% |
| Headache |
11.8% |
| Crying |
5.9% |
| Norepinephrine Increased |
5.9% |
| Pain |
5.9% |
| Psychotic Disorder |
5.9% |
| Respiratory Depression |
5.9% |
| Serotonin Syndrome |
5.9% |
| Sternal Fracture |
5.9% |
| Wound |
5.9% |
|
